GlassScriptPhysician profile
Matthew Nelson
NPI 1437584752
$482.31
in general payments reported to CMS, 2019-2025
12 companies · $48.21 in 2025
The $48.21 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.63 · 2023: $89.65 · 2024: $263 · 2025: $48.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $91.28 | 2023-2024 | Watchman Flx, Wavewriter Alpha Prime 16 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.63 | 2024-2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $49.01 | 2022 | |
| Pfizer INC. | $47.52 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $43.09 | 2024 | Rexulti |
| Exact Sciences Corporation | $42.29 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $39.48 | 2022-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $30.45 | 2024-2025 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $29.80 | 2024 | |
| Xeris Pharmaceuticals, INC. | $23.58 | 2023 | Gvoke Hypopen |
| Abbvie INC. | $19.28 | 2022 | |
| Cipher Pharmaceuticals US LLC | $13.90 | 2025 | Natroba, Spinosad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.